Singapore markets closed

EOM Pharmaceuticals Holdings, Inc. (IMUC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2680+0.0850 (+46.45%)
As of 10:24AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.1830
Open0.2680
Bid0.0000 x 900
Ask0.0000 x 3000
Day's range0.2680 - 0.2680
52-week range0.1510 - 0.4000
Volume140
Avg. volume2,703
Market cap30.357M
Beta (5Y monthly)1.38
PE ratio (TTM)0.03
EPS (TTM)10.1700
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613

    EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key pro-inflammatory and anti-inflammatory cytokines with potential therapeutic utility in treating a variety of acute and chronic inflammatory conditions.